OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 121
- +14 vs. Q1 2026
- Portfolio value
- $5.28B
- +$878.4M (+20.0%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| EWTXEdgewise Therapeutics, Inc. | COM | 15,518,492 | $630.5M | 11.9% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 6,776,632 | $343.9M | 6.5% | −1,182,906−14.9% | Reduced | History |
| LLYEli Lilly & Co | Stock | 257,900 | $309.3M | 5.9% | +21,100+8.9% | Added | History |
| MBXMBX Biosciences, Inc. | COM | 3,428,736 | $189.3M | 3.6% | −209,151−5.7% | Reduced | History |
| SVASinovac Biotech Ltd | SHS | 2,718,735 | $184.5M | 3.5% | 00.0% | Unchanged | History |
| AZNAstraZeneca PLC | ADR | 915,700 | $171.1M | 3.2% | +245,500+36.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 2,209,400 | $118.6M | 2.2% | +733,997+49.7% | Added | History |
| SIONSionna Therapeutics, Inc. | COM | 2,555,877 | $112.4M | 2.1% | −974,825−27.6% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 7,165,006 | $107.0M | 2.0% | 00.0% | Unchanged | History |
| AVBPArriVent BioPharma, Inc. | COM | 3,027,328 | $105.2M | 2.0% | 00.0% | Unchanged | History |
| GHGuardant Health, Inc. | COM | 583,700 | $87.6M | 1.7% | +148,500+34.1% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 92,880 | $86.2M | 1.6% | −44,020−32.2% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 663,400 | $85.2M | 1.6% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 1,807,486 | $83.3M | 1.6% | −328,663−15.4% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 230,100 | $77.0M | 1.5% | +57,600+33.4% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 834,900 | $75.5M | 1.4% | −395,700−32.2% | Reduced | History |
| PRLDPrelude Therapeutics Inc | COM | 13,724,571 | $73.2M | 1.4% | +2,815,315+25.8% | Added | History |
| ABVXAbivax S.A. | SPONSORED ADS | 546,522 | $72.8M | 1.4% | +80,822+17.4% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 3,235,684 | $71.9M | 1.4% | +317,800+10.9% | Added | History |
| NTRANatera, Inc. | COM | 262,000 | $71.1M | 1.3% | 00.0% | Unchanged | History |
| CGONCG Oncology, Inc. | COM | 972,800 | $69.1M | 1.3% | +24,533+2.6% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 161,100 | $67.0M | 1.3% | +161,100 | New | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 8,288,510 | $66.4M | 1.3% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | ORD SHS | 244,456 | $65.2M | 1.2% | +62,479+34.3% | Added | History |
| HUMHumana Inc | Stock | 164,100 | $65.2M | 1.2% | +164,100 | New | History |
| COGTCogent Biosciences, Inc. | COM | 1,681,300 | $65.1M | 1.2% | +1,359,200+422.0% | Added | History |
| BSXBoston Scientific Corp | Stock | 1,483,200 | $63.3M | 1.2% | −898,900−37.7% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 157,900 | $62.8M | 1.2% | −50,800−24.3% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 2,110,300 | $56.9M | 1.1% | +57,400+2.8% | Added | History |
| ODTXOdyssey Therapeutics, Inc. | COMMON STOCK | 3,001,198 | $56.2M | 1.1% | +3,001,198 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 892,471 | $53.9M | 1.0% | −167,500−15.8% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 2,042,000 | $53.5M | 1.0% | +2,042,000 | New | History |
| BMYBristol Myers Squibb Co | Stock | 925,000 | $53.3M | 1.0% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 4,127,987 | $52.6M | 1.0% | +1,875,000+83.2% | Added | History |
| SYKStryker Corp | Stock | 159,100 | $50.1M | 0.9% | −23,400−12.8% | Reduced | History |
| CAICaris Life Sciences, Inc. | COM | 2,806,811 | $50.0M | 0.9% | 00.0% | Unchanged | History |
| TMOThermo Fisher Scientific Inc. | Stock | 90,700 | $45.5M | 0.9% | +44,200+95.1% | Added | History |
| PVLAPalvella Therapeutics, Inc. | COM | 292,360 | $44.7M | 0.8% | +157,760+117.2% | Added | History |
| ELVElevance Health, Inc. | Stock | 114,700 | $44.4M | 0.8% | 00.0% | Unchanged | History |
| STTKShattuck Labs, Inc. | COM | 6,306,127 | $43.8M | 0.8% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 5,693,589 | $39.4M | 0.7% | 00.0% | Unchanged | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 999,000 | $37.4M | 0.7% | 00.0% | Unchanged | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 322,900 | $35.9M | 0.7% | +8,800+2.8% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,542,000 | $33.7M | 0.6% | +579,700+60.2% | Added | History |
| FBRXForte Biosciences, Inc. | COM NEW | 1,577,705 | $33.5M | 0.6% | +380,750+31.8% | Added | History |
| CMPXCompass Therapeutics, Inc. | COM | 15,219,994 | $33.3M | 0.6% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM NEW | 465,346 | $32.5M | 0.6% | +190,346+69.2% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 83,200 | $30.9M | 0.6% | +14,100+20.4% | Added | History |
| 0000000000 | Stock | 5,680,186 | $30.3M | 0.6% | −530,713−8.5% | Reduced | – |
| AXSMAxsome Therapeutics, Inc. | COM | 117,578 | $28.8M | 0.5% | −96,343−45.0% | Reduced | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 420,600 | $26.9M | 0.5% | +240,001+132.9% | Added | History |
| TRVITrevi Therapeutics, Inc. | COM | 1,430,293 | $26.7M | 0.5% | −1,024,107−41.7% | Reduced | History |
| IRONDisc Medicine, Inc. | COM | 357,535 | $26.2M | 0.5% | −710,015−66.5% | Reduced | History |
| WSTWest Pharmaceutical Services Inc | COM | 70,600 | $25.3M | 0.5% | +70,600 | New | History |
| RLMDRelmada Therapeutics, Inc. | COM | 3,631,195 | $25.1M | 0.5% | −1,084,669−23.0% | Reduced | History |
| URGNUroGen Pharma Ltd. | COM | 676,187 | $24.9M | 0.5% | −199,300−22.8% | Reduced | History |
| STROSutro Biopharma, Inc. | COM SHS | 743,944 | $24.7M | 0.5% | −57,200−7.1% | Reduced | History |
| SVRASavara Inc | COM | 3,959,900 | $24.4M | 0.5% | +3,324,900+523.6% | Added | History |
| NPCENeuroPace Inc | COM | 1,505,125 | $23.9M | 0.5% | −591,402−28.2% | Reduced | History |
| AURAAura Biosciences, Inc. | COM | 3,333,333 | $23.7M | 0.4% | +3,333,333 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,015,000 | $21.8M | 0.4% | −678,929−25.2% | Reduced | History |
| HELPCybin Inc. | COM NEW | 3,271,400 | $21.6M | 0.4% | −561,443−14.6% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,852,000 | $18.5M | 0.4% | +426,800+29.9% | Added | History |
| BIOABioAge Labs, Inc. | COM | 752,153 | $18.4M | 0.3% | +40,342+5.7% | Added | History |
| LXEOLexeo Therapeutics, Inc. | COM | 3,947,850 | $18.4M | 0.3% | +345,400+9.6% | Added | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 3,934,296 | $18.0M | 0.3% | −231,704−5.6% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 365,400 | $17.2M | 0.3% | −438,600−54.6% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 186,145 | $16.5M | 0.3% | +186,145 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 1,737,287 | $16.3M | 0.3% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 369,596 | $15.9M | 0.3% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 548,163 | $15.4M | 0.3% | 00.0% | Unchanged | History |
| EYPTEyePoint, Inc. | COM NEW | 1,069,147 | $15.3M | 0.3% | 00.0% | Unchanged | History |
| WATWaters Corp | COM | 40,300 | $15.1M | 0.3% | +40,300 | New | History |
| MNPRMonopar Therapeutics | COM NEW | 157,423 | $14.6M | 0.3% | +157,423 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 253,000 | $14.4M | 0.3% | +253,000 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 2,000,000 | $13.6M | 0.3% | +2,000,000 | New | History |
| BIIBBiogen Inc. | COM | 61,600 | $13.3M | 0.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 70,500 | $13.2M | 0.3% | +18,500+35.6% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 115,000 | $11.2M | 0.2% | +115,000 | New | History |
| SPRBSpruce Biosciences, Inc. | COM NEW | 200,000 | $10.8M | 0.2% | +200,000 | New | History |
| LFSTLifeStance Health Group, Inc. | COM | 947,400 | $10.1M | 0.2% | +447,400+89.5% | Added | History |
| ERASErasca, Inc. | COM | 495,900 | $9.08M | 0.2% | +495,900 | New | History |
| TARAProtara Therapeutics, Inc. | COM STK | 2,220,000 | $8.48M | 0.2% | +2,220,000 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 759,155 | $8.12M | 0.2% | 00.0% | Unchanged | History |
| JANXJanux Therapeutics, Inc. | COM | 524,700 | $8.06M | 0.2% | −458,900−46.7% | Reduced | History |
| TECXTectonic Therapeutic, Inc. | COM | 226,600 | $7.79M | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM NEW | 844,787 | $7.30M | 0.1% | −183,157−17.8% | Reduced | History |
| PHVSPharvaris N.V. | COM | 205,400 | $7.10M | 0.1% | 00.0% | Unchanged | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 257,852 | $6.80M | 0.1% | +90,352+53.9% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 1,390,576 | $6.74M | 0.1% | +1,390,576 | New | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 93,000 | $6.53M | 0.1% | +53,000+132.5% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 2,866,256 | $5.93M | 0.1% | 00.0% | Unchanged | History |
| Travere Therapeutics, Inc.89422GAB3 | NOTE 0.500% 5/1 | – | $5.89M | 0.1% | – | New | – |
| XLOXilio Therapeutics, Inc. | COM | 592,300 | $5.67M | 0.1% | +592,300 | New | History |
| BCAXBicara Therapeutics Inc. | COM | 191,100 | $5.67M | 0.1% | −476,200−71.4% | Reduced | History |
| IMAImageneBio, Inc. | COM | 909,269 | $5.36M | 0.1% | +530,713+140.2% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 42,100 | $5.16M | 0.1% | 00.0% | Unchanged | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 17,000 | $5.12M | 0.1% | −102,000−85.7% | Reduced | History |
| PALIPalisade Bio, Inc. | COM | 2,333,000 | $4.88M | 0.1% | 00.0% | Unchanged | History |
| Revolution Medicines, Inc.76155XAA8 | NOTE 0.500% 5/0 | – | $4.38M | 0.1% | – | New | – |
Options (8)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $47.5M | – |
| ABVXAbivax S.A. | SPONSORED ADS | – | $26.7M |
| PTGXProtagonist Therapeutics, Inc | COM | – | $18.4M |
| RVMDRevolution Medicines, Inc. | COM | – | $9.36M |
| PVLAPalvella Therapeutics, Inc. | COM | – | $6.11M |
| UNHUnitedHealth Group Inc | Stock | – | $4.16M |
| ELVElevance Health, Inc. | Stock | – | $3.87M |
| SLSSELLAS Life Sciences Group, Inc. | COM NEW | $1.37M | – |
Sold out since Q1 2026 (20)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| MYGNMyriad Genetics Inc | COM | – | $122.9M | 2.8% | History |
| PFEPfizer Inc | Stock | 1,946,500 | $54.7M | 1.2% | History |
| DHRDanaher Corp | Stock | 265,800 | $50.4M | 1.1% | History |
| RCELAVITA Medical, Inc. | COM | 544,895 | $42.5M | 1.0% | History |
| ESPREsperion Therapeutics, Inc. | COM | 10,570,300 | $29.0M | 0.7% | History |
| BTSGBrightSpring Health Services, Inc. | COM | 497,800 | $21.2M | 0.5% | History |
| AMGNAmgen Inc | Stock | 39,900 | $14.0M | 0.3% | History |
| ALHCAlignment Healthcare, Inc. | COM | 791,000 | $13.9M | 0.3% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 14,700 | $11.4M | 0.3% | History |
| CARLCarlsmed, Inc. | COM | 1,252,600 | $11.3M | 0.3% | History |
| GILDGilead Sciences, Inc. | Stock | 59,600 | $8.31M | 0.2% | History |
| HRTXHeron Therapeutics, Inc. | COM | 9,816,940 | $7.85M | 0.2% | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 475,165 | $7.09M | 0.2% | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,150,646 | $6.36M | 0.1% | History |
| ADCTADC Therapeutics SA | SHS | 1,318,026 | $4.94M | 0.1% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 243,006 | $3.45M | 0.1% | History |
| JBIOJade Biosciences, Inc. | COM NEW | 185,011 | $2.60M | 0.1% | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 856,353 | $2.25M | 0.1% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 94,400 | $1.90M | <0.1% | History |
| VTGNVistagen Therapeutics, Inc. | COM | 3,060,000 | $1.75M | <0.1% | History |